Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss webster mice

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 2, 1997, Pages 243-249

  Rady, Jodie J ^a,d   Baemmert, Daniel ^a   Takemori, A E ^b   Portoghese, P S ^c   Fujimoto, James M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

6 monoacetylmorphine; 7 benzylidenena ltrexone; antinociception; DPDPE; DSLET; naltriben; spinal delta opioid receptor subtype

Indexed keywords

7 BENZYLIDENENALTREXONE; BETA ENDORPHIN; DELTA OPIATE RECEPTOR; DIAMORPHINE; ENKEPHALIN DERIVATIVE; MORPHINE 6 ACETATE; NALTRIBEN; OPIATE ANTAGONIST; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; BENZYLIDENE COMPOUNDS; BETA-ENDORPHIN; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; MORPHINE DERIVATIVES; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RECEPTORS, OPIOID, DELTA; SPINAL CORD;

EID: 0031043999     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00219-5     Document Type: Article

References (46)

1. 5 (DAMGO) and morphine-induced antinociception in mice. J. Pharmacol. Exp. Ther. 256:890-896; 1991.
2. 4]-deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor. Life Sci. 55:PL 37-43; 1994.
3. Corbett, A. D.; Gillan, M. G. E.; Kosterlitz, W. W.; McKnight, A. T.; Paterson, S. J.; Robson, L. E. Selectivities of opioid peptide analogues as agonists at the δ-receptor. Br. J. Pharmacol. 83:271-279; 1984.
4. D'Amour, F. E.; Smith, D. L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:74-79; 1941.
5. Dewey, W. L.; Harris, L. S.; Howes, J. P.; Nuite, J. A. The effect of various neurohormonal modulators on the activity of morphine and the narcotic antagonists in the tail flick and phenylquinone test. J. Pharmacol. Exp. Ther. 175:435-442; 1970.
6. Gacel, G.; Fournie-Zaluski, M-C.; Roques, B. P. D-Tyr-Ser-Gly-Phe-Leu-Thre, a highly preferential ligand for δ-opioid receptors. FEBS Lett. 118:245-247; 1980.
7. Haley, T. J.; McCormick, W. G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12:12-15; 1957.
8. 5]enkephalin, a delta opioid agonist, given intracerebroventricularly in the mouse produces antinociception through mediation of spinal GABA receptors. Pharmacol. Biochem. Behav. 49:675-682; 1994.
9. Hylden, J. L.; Wilcox, G. L. Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67:313-316; 1980.
10. Inturrisi, C. E.; Schultz, M.; Shin, S.; Umans, J. G.; Angel, L.; Simon, E. J. Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci. 3(suppl I):773-776; 1983.
11. Jiang, Q.; Mosberg, H. I.; Porreca, F. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J. Pharmacol. Exp. Ther. 254:683-689; 1990.
12. 6]enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257:1069-1075; 1991.
13. Mattia, A.; Farmer, S. C.; Takemori, A. E.; Sultana, M.; Portoghese, P. S.; Mosberg, H. I.; Bowen, W. D.; Porreca, F. Spinal delta antinociception in the mouse: Mediation by a 5′-NTII-sensitive delta receptor subtype. J. Pharmacol. Exp. Ther. 260:518-525; 1992.
14. 2]deltorphin II in mice: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258:583-587; 1991.
15. Pick, C. G.; Nejat, R. J.; Pasternak, G. W. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J. Pharmacol. Exp. Ther. 265:166-171; 1993.
16. Porreca, F.; Takemori, A. E.; Sultana, M.; Portoghese, P. S.; Bowen, W. D.; Mosberg, H. I. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J. Pharmacol. Exp. Ther. 263:147-152; 1992,
17. 1-opioid receptor antagonist: 7-benzylidenenaltrexone. Eur. J. Pharmacol. 218:195-196; 1992.
18. Portoghese, P. S.; Sultana, M.; Nagase, H.; Takemori, A. E. Application of the message-address concept in the design of highly potent and selective non-peptide δ opioid receptor antagonists. J. Med. Chem. 31:281-282; 1988.
19. Rady, J. J.; Aksu, F.; Fujimoto, J. M. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice. J. Pharmacol. Exp. Ther. 268:1222-1231; 1994.
20. Rady, J. J.; Fujimoto, J. M. Spinal GABA receptors mediate brain delta opioid analgesia in Swiss Webster mice. Pharmacol. Biochem. Behav. 51:655-659; 1995.
21. A receptors. Pharmacol. Biochem. Behav. 54:363-369; 1996.
22. Rady, J. J.; Roerig, S. C.; Fujimoto, J. M. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. J. Pharmacol. Exp. Ther. 256:448-457; 1991.
23. Rady, J. J.; Takemori, A. E.; Portoghese, P. S.; Fujimoto, J. M. Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice. Life Sci. 55:603-609; 1994.
24. Roerig, S. C.; Fujimoto, J. M. and Tseng, L. F. Comparisons of descending pain inhibitory pathways activated by β-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice. J. Pharmacol. Exp. Ther. 247:1107-1113; 1988.
25. Sofuoglu, M.; Portoghese, P. S.; Takemori, A. E. Cross-tolerance studies in the spinal cord of β-FNA-treated mice provides further evidence for delta opioid receptor subtypes. Life Sci. 49:PL-153-PL-156, 1991.
26. Sofuoglu, M.; Portoghese, P. S.;Takemori, A. E. δ-opioid receptor binding in mouse brain: Evidence for heterogeneous binding sites. Eur. J. Pharmacol. 216:273-277; 1992.
27. Sofuoglu, M.; Portoghese, P. S.; Takemori, A. E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257:676-680; 1991.
28. Steel, R. G. D.; Torrie, J. H. Principles and procedures of statistics with special reference to the biological sciences. New York: McGraw-Hill Book Company, Inc.; 1960:99-111.
29. Suh, H. H.; Tseng, L. F. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by β-endorphin given intracerebroventricularly in mice. J. Pharmacol. Exp. Ther. 253:981-986; 1990.
30. 2-opioid receptors in the brain and spinal cord, respectively. Eur. J. Pharmacol. 242:145-150; 1993.
31. Takemori, A. E.; Portoghese, P. S. Receptors for opioid peptides in the guinea-pig ileum. J. Pharmacol. Exp. Ther. 235:389-392; 1985.
32. Takemori, A. E.; Sultana, M.; Portoghese, P. S. Agonist and antagonist activities of ligands derived from naltrexone and oxymor-phone. Life Sci. 50:1491-1495; 1992.
33. Tseng, L. F.; Collins, K. A. Antisense oligodeoxynucleotide to a δ-opioid receptor given intrathecally blocks I.C.V. administered β-endorphin-induced antinociception in the mouse. Life Sci. 55:PL 127-131; 1994.
34. Tseng, L. F.; Collins, K. A.; Kampine, J. P. Antisense oligodeoxynucleotide to a δ-opioid receptor selectively blocks the spinal antinociception induced by δ-, but not (μ- or κ-opioid receptor agonists in the mouse. Eur. J. Pharmacol. 258:R1-R3; 1994.
35. 1 opioid receptors are involved in intracerebroventricular β-endorphin-induced antinociception in the mouse. Life Sci. 52:PL 211-215; 1993.
36. 5]enkephalin and cholecystokinin from the spinal cord by β-endorphin administered intraventricularly in the pentobarbital-anesthetized rat. Eur. J. Pharmacol. 215:309-312; 1992.
37. 5]enkephalin antibody blocks analgesia induced by intracerebroventricular ß-endorphin but not morphine in mice. Eur. J. Pharmacol. 173:171-176; 1989.
38. Umans, J. G.; Inturrisi, C. E. Heroin: Analgesia, toxicity and disposition in the mouse. Eur. J. Pharmacol. 85:317-323; 1982.
39. Umans, J. G.; Inturrisi, C. E. Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice. J. Pharmacol. Exp. Ther. 218:409-415; 1981.
40. von Zastrow, M.; Keith, D. E.; Evans, C. J. Agonist-induced state of the δ-opioid receptor that discriminates between opioid peptides and opiate alkaloids. Molecular Pharmacol. 44:166-172; 1993.
41. Ward, S. J.; LoPresti, D.; James, D. W. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: Differentiation into peptide and nonpeptide classes with β-funaltrexamine. J. Pharmacol. Exp. Ther. 238:625-631; 1986.
42. Way, E. L. Brain uptake of morphine: Pharmacologic implications. Fed. Proc. 26:1115-1118; 1967b.
43. Way, E. L. Metabolism of analgesics: Pharmacologic implications of some factors influencing brain uptake of morphine. Arch. Biol. Med. Exp. 4:92-104; 1967a.
44. Way, E. L.; Adler, T. K. The pharmacologic implications of the fate of morphine and its surrogates. Pharmacol. Rev. 12:383-446; 1960.
45. Way, E. L.; Kemp, J. W.; Young, J. M.; Grassetti, D. R. The pharmacologic effects of heroin in relationship to its rate of biotransformation. J. Pharmacol. Exp. Ther. 129:144-154; 1960.
46. Wigdor, S.; Wilcox, G. L. Central and systemic morphine-induced antinociception in mice: Contribution of descending serotonergic and noradrenergic pathways. J. Pharmacol. Exp. Ther. 242: 90-95; 1987.